CVC  Roche Venture Fund

http://www.roche.com/venturefund.htm





     Office Locations:

Genentech, Inc. 1 DNA Way
South San Francisco, CA 94080
Phone: 650-225-1000

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Growth


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    The Roche Venture Fund is the corporate venture fund of the healthcare company Roche. The fund invests in innovative biotech and diagnostics companies to develop commercially successful life science companies. Roche has allocated CHF 500 million to invest in and develop commercially successful innovative life science companies. RVF invests globally with a portfolio of over 30 companies in 10 countries. Initial investment ranges from CHF 3-10 million, depending on the stage of the company, the pre-money valuation, and the amount being raised. In general, RVP prefers to be in the 15% ownership range. Areas of particular interest to the fund include: oncology, central nervous system, inflammation, virology, in vitro diagnostics, and molecular diagnostics. To date, Roche has had over 20 exits on the public markets and 12 of our portfolio companies have been acquired.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Carole Nuechterlein Head, Roche Venture Fund
    David Evans Investment Director
    Monique Schiersing Senior Investment Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      04/28/2021


      Arch Oncology


      CA


      $105,000,000


      Series C


     

    Portfolio companies include:

     

    Recent News: